A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis.
A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis. — المؤلف: Deodhar, Atul — Arthritis & rheumatology (Hoboken, N.J.) 20200106
- المؤلف
- Deodhar, Atul
- النشر
- Arthritis & rheumatology (Hoboken, N.J.) 20200106
- الوصف
- 1101-1111 p.
- الموضوعات
- Adult؛ C-Reactive Protein؛ Certolizumab Pegol؛ Double-Blind Method؛ Female؛ Humans؛ Magnetic Resonance Imaging؛ Male